ATE335071T1 - Bakterien der gattung bifidobacterium longum und bakterien enthaltende zusammensetzung - Google Patents
Bakterien der gattung bifidobacterium longum und bakterien enthaltende zusammensetzungInfo
- Publication number
- ATE335071T1 ATE335071T1 AT03013441T AT03013441T ATE335071T1 AT E335071 T1 ATE335071 T1 AT E335071T1 AT 03013441 T AT03013441 T AT 03013441T AT 03013441 T AT03013441 T AT 03013441T AT E335071 T1 ATE335071 T1 AT E335071T1
- Authority
- AT
- Austria
- Prior art keywords
- bacteria
- bifidobacterium longum
- composition containing
- genus bifidobacterium
- strain
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
- A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
- A23C19/00—Cheese; Cheese preparations; Making thereof
- A23C19/02—Making cheese curd
- A23C19/032—Making cheese curd characterised by the use of specific microorganisms, or enzymes of microbial origin
- A23C19/0323—Making cheese curd characterised by the use of specific microorganisms, or enzymes of microbial origin using only lactic acid bacteria, e.g. Pediococcus and Leuconostoc species; Bifidobacteria; Microbial starters in general
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
- A23C19/00—Cheese; Cheese preparations; Making thereof
- A23C19/06—Treating cheese curd after whey separation; Products obtained thereby
- A23C19/061—Addition of, or treatment with, microorganisms
- A23C19/062—Addition of, or treatment with, microorganisms using only lactic acid bacteria, e.g. pediococcus, leconostoc or bifidus sp., or propionic acid bacteria; Treatment with non-specified acidifying bacterial cultures
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
- A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/533—Longum
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Mycology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nutrition Science (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Animal Husbandry (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Physiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000564A ITBO20020564A1 (it) | 2002-09-06 | 2002-09-06 | Bifidobatteri e preparazioni che li contengono. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE335071T1 true ATE335071T1 (de) | 2006-08-15 |
Family
ID=31726535
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03013441T ATE335071T1 (de) | 2002-09-06 | 2003-06-23 | Bakterien der gattung bifidobacterium longum und bakterien enthaltende zusammensetzung |
| AT05011028T ATE376053T1 (de) | 2002-09-06 | 2003-06-23 | Bakterien der gattung bifidobacterium longum und bakterien enthaltende zusammensetzung |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05011028T ATE376053T1 (de) | 2002-09-06 | 2003-06-23 | Bakterien der gattung bifidobacterium longum und bakterien enthaltende zusammensetzung |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US6960341B2 (de) |
| EP (2) | EP1609852B1 (de) |
| JP (1) | JP4011532B2 (de) |
| KR (1) | KR100574455B1 (de) |
| CN (1) | CN100386427C (de) |
| AT (2) | ATE335071T1 (de) |
| CA (1) | CA2436752C (de) |
| DE (2) | DE60307191T2 (de) |
| DK (2) | DK1609852T3 (de) |
| ES (2) | ES2268226T3 (de) |
| IT (1) | ITBO20020564A1 (de) |
| PT (2) | PT1609852E (de) |
| SI (2) | SI1609852T1 (de) |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7029702B2 (en) * | 1998-07-07 | 2006-04-18 | Ritter Natural Sciences Llc | Method for increasing lactose tolerance in mammals exhibiting lactose intolerance |
| EP2251017B1 (de) | 2002-05-20 | 2015-03-25 | Cedars-Sinai Medical Center | Manipulation der Rate des Gastrointestinalen Transits durch Modulation der Methankonzentration im Darm |
| US10066254B2 (en) | 2002-05-20 | 2018-09-04 | Cedars-Sinai Medical Center | Diagnosis of constipation by analysis of methane concentration |
| JP2007518693A (ja) * | 2003-08-18 | 2007-07-12 | ザ バイオ バランス コーポレイション | 安定な液体プロバイオティクス組成物、その調製および適用 |
| US20080126195A1 (en) * | 2004-07-22 | 2008-05-29 | Ritter Andrew J | Methods and Compositions for Treating Lactose Intolerance |
| US20100233312A9 (en) * | 2005-04-11 | 2010-09-16 | The Procter & Gamble Company | Compositions comprising probiotic and sweetener components |
| CN101454440B (zh) | 2006-05-28 | 2013-05-29 | 西普拉梅德普罗研究与发展有限公司 | 益生菌株以及从其衍生的抗微生物肽 |
| BRPI0810087A2 (pt) * | 2007-03-28 | 2014-10-21 | Alimentary Health Ltd | Cepas de bifidobacterium probióticas |
| CN101998859B (zh) * | 2008-03-18 | 2014-03-05 | 亚历山大·弗拉基米罗维奇·季科夫斯基 | 用于预防与抗生素肠道给药相关的生态失调的药物组合物 |
| US9771199B2 (en) | 2008-07-07 | 2017-09-26 | Mars, Incorporated | Probiotic supplement, process for making, and packaging |
| US20110189148A1 (en) * | 2008-06-25 | 2011-08-04 | Ritter Pharmaceuticals, Inc. | Lactose compositions with decreased lactose content |
| ES2331863B1 (es) * | 2008-07-15 | 2010-10-27 | Consejo Superior De Investigaciones Cientificas (Csic) | Bacterias y productos derivados para fortalecer las defensas y reducir el riesgo de enfermedad. |
| KR101017448B1 (ko) * | 2008-09-18 | 2011-02-23 | 주식회사한국야쿠르트 | 대장의 건강 증진 효능을 갖는 비피도박테리움 롱검 에이취와이8004 및 이를 유효성분으로 함유하는 제품 |
| SG2014014435A (en) | 2009-02-24 | 2014-07-30 | Ritter Pharmaceuticals Inc | Prebiotic formulations and methods of use |
| CN101649303B (zh) * | 2009-05-08 | 2011-09-28 | 内蒙古蒙牛乳业(集团)股份有限公司 | 一种双歧杆菌及其应用和含有双歧杆菌的食品组合物 |
| MY159273A (en) * | 2009-05-11 | 2016-12-30 | Nestec Sa | Bifidobacterium longum ncc2705 (cncm i-2618) and immune disorders |
| EP2270134A1 (de) * | 2009-07-03 | 2011-01-05 | Nestec S.A. | Gegen oxidativen Stress resistente Bifido-Bakterien |
| WO2011137249A1 (en) | 2010-04-28 | 2011-11-03 | Ritter Pharmaceuticals, Inc. | Prebiotic formulations and methods of use |
| RU2470518C1 (ru) * | 2011-05-27 | 2012-12-27 | Закрытое акционерное общество "АЛЕВ" | Молочный йогурт с пробиотическими культурами |
| WO2013130773A2 (en) | 2012-02-29 | 2013-09-06 | Ethicon Endo-Surgery, Inc. | Compositions of microbiota and methods related thereto |
| CA2903493C (en) | 2013-03-15 | 2022-05-31 | Cedars-Sinai Medical Center | Methods of diagnosis, selection, and treatment of diseases and conditions caused by or associated with methanogens |
| US9289418B2 (en) | 2013-03-15 | 2016-03-22 | Cedars-Sinai Medical Center | Methods of diagnosis, selection, and treatment of diseases and conditions caused by or associated with methanogens |
| CN104095180A (zh) * | 2013-04-12 | 2014-10-15 | 中国科学院烟台海岸带研究所 | 一种益生菌菊粉片及其制备方法 |
| JP6637885B2 (ja) | 2013-07-21 | 2020-01-29 | ペンデュラム セラピューティクス, インコーポレイテッド | マイクロバイオームの特性解明、モニタリング、および処置のための方法およびシステム |
| BR112017002761A2 (pt) | 2014-08-13 | 2017-12-19 | Cedars Sinai Medical Center | composições anti-metanogênicas e usos das mesmas |
| SG11201703395PA (en) | 2014-10-31 | 2017-05-30 | Whole Biome Inc | Methods and compositions relating to microbial treatment and diagnosis of disorders |
| EP3277274B1 (de) | 2015-04-01 | 2024-06-12 | Cedars-Sinai Medical Center | Antimethanogene lovastatin-analoga oder -derivate und verwendungen davon |
| EP3288554B1 (de) * | 2015-04-30 | 2022-08-24 | Probiotical S.p.A. | Verwendung von antibiotika mit spezifischen therapeutischen wirkungen, kombiniert mit gleichzeitiger verwendung von lactobacilli und/oder bifidobakterien mit einer nicht-übertragbaren antibiotikaresistenz mit derselben therapeutischen indikation |
| KR20180016507A (ko) | 2015-06-08 | 2018-02-14 | 시에이치알. 한센 에이/에스 | 프로바이오틱 박테리아가 함유된 글리세린-기재 구미 캔디 및 발포 캔디 제품 |
| CN105112333A (zh) * | 2015-08-31 | 2015-12-02 | 江南大学 | 一种具有良好肠道定殖能力的长双歧杆菌及筛选方法和应用 |
| BR112019011744B1 (pt) | 2016-12-14 | 2023-04-11 | Chr. Hansen A/S | Produtos de confeitaria espumosos à base de glicerina e proteína com bactérias probióticas e seus processos de preparação |
| CN110475479A (zh) | 2017-01-31 | 2019-11-19 | 堪萨斯州立大学研究基金会 | 微生物细胞、产生其的方法以及其用途 |
| CN106978340B (zh) * | 2017-06-04 | 2018-01-30 | 合肥职业技术学院 | 一种双歧杆菌专用培养装置 |
| CN111372596A (zh) | 2017-08-30 | 2020-07-03 | 潘德勒姆治疗公司 | 用于治疗微生物组相关病症的方法和组合物 |
| CN113164526A (zh) | 2018-07-19 | 2021-07-23 | 潘德勒姆治疗公司 | 用于微生物植入的方法和组合物 |
| CN110438042A (zh) * | 2019-07-23 | 2019-11-12 | 广东益可维健康科技有限公司 | 一株长双歧杆菌及其应用 |
| KR102607676B1 (ko) * | 2019-12-04 | 2023-11-29 | 선 바이오 (주) | 내산소성 비피도박테리움 균주를 유효성분으로 포함하는 반려동물용 생균제 조성물 및 이의 제조방법 |
| CN112353823A (zh) * | 2020-12-16 | 2021-02-12 | 梁爱军 | 一种能在胃肠同时发挥作用的益生菌液 |
| CN112715660A (zh) * | 2021-01-18 | 2021-04-30 | 润盈生物工程(上海)有限公司 | 一种干预慢性肾炎及尿毒症的长双歧杆菌膳食组合及应用 |
| CN115474695B (zh) * | 2021-05-31 | 2024-01-19 | 仙乐健康科技股份有限公司 | 一种调节宿主肠道微生物平衡的制剂 |
| JP2023077698A (ja) * | 2021-11-25 | 2023-06-06 | アスパック企業株式会社 | 腸内環境改善剤 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0768375B2 (de) * | 1992-07-06 | 2002-06-12 | Societe Des Produits Nestle S.A. | Milchbakterien |
| US6241983B1 (en) | 1994-10-28 | 2001-06-05 | Metagenics, Inc. | Bacteria-and fiber-containing composition for human gastrointestinal health |
| US6306638B1 (en) * | 1996-10-22 | 2001-10-23 | Food Industry Research And Development Institute | Mutant bifidobacteria strains with acid, bile salt and oxygen tolerance |
| ATE169456T1 (de) * | 1996-12-23 | 1998-08-15 | Sitia Yomo Spa | Lyophilisierte, lebende bakerien enthaltende nahrungszusammensetzung |
| SI0931543T1 (en) * | 1997-12-19 | 2002-10-31 | Merck Patent Gmbh | Multilayered tablet comprising probiotic microorganisms such as lactobacilli or bifidobacteria |
| WO1999033854A1 (en) | 1997-12-26 | 1999-07-08 | Research Development Foundation | Mammalian circadian regulator m-rigui2 (m-per2) |
| CN1325285A (zh) | 1998-08-24 | 2001-12-05 | 马丁·C·巴鲁克 | 脉搏传输时间测量装置和方法 |
| NL1010770C2 (nl) * | 1998-12-09 | 2000-06-13 | Nutricia Nv | Preparaat dat oligosacchariden en probiotica bevat. |
| CN1198631C (zh) * | 1999-08-05 | 2005-04-27 | 雀巢制品公司 | 双歧杆菌在制备预防腹泻药物中的用途 |
-
2002
- 2002-09-06 IT IT000564A patent/ITBO20020564A1/it unknown
-
2003
- 2003-06-23 AT AT03013441T patent/ATE335071T1/de active
- 2003-06-23 PT PT05011028T patent/PT1609852E/pt unknown
- 2003-06-23 ES ES03013441T patent/ES2268226T3/es not_active Expired - Lifetime
- 2003-06-23 DE DE60307191T patent/DE60307191T2/de not_active Expired - Lifetime
- 2003-06-23 SI SI200331036T patent/SI1609852T1/sl unknown
- 2003-06-23 AT AT05011028T patent/ATE376053T1/de active
- 2003-06-23 DK DK05011028T patent/DK1609852T3/da active
- 2003-06-23 SI SI200330486T patent/SI1398369T1/sl unknown
- 2003-06-23 ES ES05011028T patent/ES2293419T3/es not_active Expired - Lifetime
- 2003-06-23 EP EP05011028A patent/EP1609852B1/de not_active Expired - Lifetime
- 2003-06-23 PT PT03013441T patent/PT1398369E/pt unknown
- 2003-06-23 DE DE60316995T patent/DE60316995T2/de not_active Expired - Lifetime
- 2003-06-23 EP EP03013441A patent/EP1398369B1/de not_active Expired - Lifetime
- 2003-06-23 DK DK03013441T patent/DK1398369T3/da active
- 2003-06-28 KR KR1020030042957A patent/KR100574455B1/ko not_active Expired - Fee Related
- 2003-07-15 CN CNB031784011A patent/CN100386427C/zh not_active Expired - Lifetime
- 2003-07-17 US US10/621,296 patent/US6960341B2/en not_active Expired - Lifetime
- 2003-08-07 CA CA002436752A patent/CA2436752C/en not_active Expired - Lifetime
- 2003-09-05 JP JP2003314690A patent/JP4011532B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| SI1398369T1 (sl) | 2006-12-31 |
| US20040047850A1 (en) | 2004-03-11 |
| EP1609852B1 (de) | 2007-10-17 |
| EP1398369B1 (de) | 2006-08-02 |
| DE60316995T2 (de) | 2008-07-24 |
| ITBO20020564A1 (it) | 2004-03-07 |
| PT1609852E (pt) | 2008-01-25 |
| DE60307191T2 (de) | 2007-07-26 |
| EP1609852A1 (de) | 2005-12-28 |
| CA2436752C (en) | 2010-02-02 |
| CN100386427C (zh) | 2008-05-07 |
| CA2436752A1 (en) | 2004-03-06 |
| SI1609852T1 (sl) | 2008-02-29 |
| DK1398369T3 (da) | 2006-10-23 |
| ES2293419T3 (es) | 2008-03-16 |
| JP2004097222A (ja) | 2004-04-02 |
| ATE376053T1 (de) | 2007-11-15 |
| JP4011532B2 (ja) | 2007-11-21 |
| PT1398369E (pt) | 2006-12-29 |
| DK1609852T3 (da) | 2007-12-27 |
| DE60307191D1 (de) | 2006-09-14 |
| EP1398369A1 (de) | 2004-03-17 |
| DE60316995D1 (de) | 2007-11-29 |
| KR20040022386A (ko) | 2004-03-12 |
| KR100574455B1 (ko) | 2006-04-27 |
| ES2268226T3 (es) | 2007-03-16 |
| CN1480528A (zh) | 2004-03-10 |
| US6960341B2 (en) | 2005-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE335071T1 (de) | Bakterien der gattung bifidobacterium longum und bakterien enthaltende zusammensetzung | |
| JP7801294B2 (ja) | クロストリジウム・ディフィシル感染症の治療における新たな使用 | |
| Ehrlich et al. | The distributed genome hypothesis as a rubric for understanding evolution in situ during chronic bacterial biofilm infectious processes | |
| Taheur et al. | Anti-bacterial and anti-biofilm activity of probiotic bacteria against oral pathogens | |
| Alghamdi | Isolation and identification of the oral bacteria and their characterization for bacteriocin production in the oral cavity | |
| NO20051651L (no) | Naeringspreparater inneholdende synbiotiske forbindelser | |
| PE20010829A1 (es) | Alimento para mascotas destinado al tratamiento de la especie helicobacter en las mascotas | |
| Ahire et al. | Survival and germination of Bacillus clausii UBBC07 spores in in vitro human gastrointestinal tract simulation model and evaluation of clausin production | |
| US10653728B2 (en) | Probiotic compositions for improving metabolism and immunity | |
| Macfarlane, MJ Hopkins, GT Macfarlane | Bacterial growth and metabolism on surfaces in the large intestine | |
| SE0402406L (sv) | Probiotiska lactobacillusstammar för förbättrad vaginal hälsa | |
| Schultz et al. | Green fluorescent protein for detection of the probiotic microorganism Escherichia coli strain Nissle 1917 (EcN) in vivo | |
| Liu et al. | Differential response of Streptococcus mutans towards friend and foe in mixed-species cultures | |
| EP1923065A4 (de) | Cholesterol-absorptionsinhibitor | |
| Modesto et al. | Bifidobacterium callitrichidarum sp. nov. from the faeces of the emperor tamarin (Saguinus imperator) | |
| BR112020019979A2 (pt) | Composições e métodos para tratamento de doenças inflamatórias intestinais | |
| US8852917B2 (en) | Thuricin CD, an antimicrobial for specifically targeting Clostridium difficile | |
| Balaganesh et al. | Probiotic curd as antibacterial agent against pathogens causing oral deformities–in vitro microbiological study | |
| DE60326049D1 (de) | Zusammensetzung zur förderung der vermehrung von lactobacillus casei subsp. casei | |
| Zhi et al. | Evaluation of in vitro probiotic properties and colonization of Brevibacillus Laterosporus S62-9 in the intestine of broiler chickens | |
| Olsvik et al. | Production of enterotoxin by Escherichia coli at four, twenty-two and thirty-seven degrees centigrade | |
| RU2617946C1 (ru) | Штаммы Lactobacillus brevis и Lactobacillus rhamnosus с установленной последовательностью генома, синтезирующие глутатион и комплекс внутриклеточных антиоксидантов | |
| Maďar et al. | Methods for Searching of Potential | |
| ITMI20041232A1 (it) | Composizione nutraceutica contenente un numero elevato di fermenti lattici utile come sinbiotico | |
| Douillard et al. | Lactic acid bacteria and the human intestinal microbiome |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1398369 Country of ref document: EP |